Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals

[Background] Despite classical association between metabolic dysfunction–associated steatotic liver disease (MASLD) and obesity, there is increasing evidence on the development of MASLD in lean individuals. The aim of the study was to assess the prevalence and risk factors of MASLD and significant l...

ver descrição completa

Detalhes bibliográficos
Autores: Martínez-Domínguez, Samuel J., García-Mateo, Sandra, Gargallo-Puyuelo, Carla J., Gallego Llera, Beatriz, Callau, Pilar, Mendi, Carolina, Arroyo-Villarino, María Teresa, Simón Marco, Miguel Ángel, Ampuero, Javier, Gomollón, Fernando
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2024
País:España
Recursos:Consejo Superior de Investigaciones Científicas (CSIC)
Repositório:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/386660
Acesso em linha:http://hdl.handle.net/10261/386660
https://api.elsevier.com/content/abstract/scopus_id/85200404348
Access Level:Acceso aberto
Palavra-chave:Ulcerative colitis
Crohn’s disease
Inflammatory bowel disease
Lean MASLD
Liver fibrosis
Descrição
Resumo:[Background] Despite classical association between metabolic dysfunction–associated steatotic liver disease (MASLD) and obesity, there is increasing evidence on the development of MASLD in lean individuals. The aim of the study was to assess the prevalence and risk factors of MASLD and significant liver fibrosis in lean participants with inflammatory bowel disease (IBD).

Registros relacionados